Crossmark

CHCHD4 confers metabolic vulnerabilities to tumour cells through its control of the mitochondrial respiratory chain

Crossref DOI link: https://doi.org/10.1186/s40170-019-0194-y

Published Online: 2019-03-06

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Thomas, Luke W.

Stephen, Jenna M.

Esposito, Cinzia

Hoer, Simon

Antrobus, Robin

Ahmed, Afshan

Al-Habib, Hasan

Ashcroft, Margaret https://orcid.org/0000-0002-0066-3707
Funding

Funding for this research was provided by:

Medical Research Council (MR/K002201/1, MR/K002201/2, RG70550, RG86932)

Cancer Research UK (C7358/A8020, C7358/A19442)

Wellcome Trust (096956/Z/11/Z)
License Information

Text and Data Mining valid from 2019-03-06
More Information

Article History

Received: 2 January 2019

Accepted: 5 February 2019

First Online: 6 March 2019

Authors’ information

: Not applicable.

: This study did not involve human participation, personal data or use of human tissue.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.